Article Text

Learning from errors
A patient’s informative mistake: niacin is very effective in correcting dyslipidaemia
  1. Michelle Fung1,
  2. Jiri Frohlich2
  1. 1
    University of British Columbia, Medicine, 4117-2775 Laurel Street, Vancouver, British Columbia, V5Z1M9, Canada
  2. 2
    University of British Columbia, Pathology, St Paul’s Hospital Healthy Heart Program, Vancouver, British Columbia, V6Z 1Y6, Canada
  1. Jiri Frohlich, jifr{at}unixg.ubc.ca

Summary

A 72-year-old man at high risk for cardiovascular disease, with a history of peripheral vascular disease and type 2 diabetes, presented with lipids above targets despite maximum daily treatment with atorvastatin 80 mg, fenofibrate supra 160 mg daily, and ezetimibe 10 mg. His low density lipoprotein cholesterol (LDL-C) was 2.6 mmol/l, total cholesterol: HDL ratio 5.6, and high density lipoprotein cholesterol (HDL-C) 0.9 mmol/l. Because his lipids were not within target, he was advised to start 2250 mg of niacin in three divided doses daily. For 5 months, he mistakenly took 2250 mg of niacin three times daily, a consumption of 6750 mg/day! The effects on his lipids were: HDL-C increased nearly 100% to 1.7 mmol/l, LDL-C decreased by 50% to 1.3 mmol/l, and cholesterol: HDL ratio decreased by over 50% to 2.1. His excessive intake dramatically demonstrates the positive effect of niacin on lipids. Fortunately he did not suffer adverse effects from taking more than the recommended limit of 3000 mg/day.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Competing interests: None.

  • Patient consent: Patient/guardian consent was obtained for publication.